Torbjørn Wisløff

2.8k total citations
114 papers, 1.9k citations indexed

About

Torbjørn Wisløff is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Torbjørn Wisløff has authored 114 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Economics and Econometrics, 24 papers in Cardiology and Cardiovascular Medicine and 22 papers in Epidemiology. Recurrent topics in Torbjørn Wisløff's work include Health Systems, Economic Evaluations, Quality of Life (28 papers), Cancer survivorship and care (14 papers) and Pharmaceutical Economics and Policy (9 papers). Torbjørn Wisløff is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (28 papers), Cancer survivorship and care (14 papers) and Pharmaceutical Economics and Policy (9 papers). Torbjørn Wisløff collaborates with scholars based in Norway, United Kingdom and United States. Torbjørn Wisløff's co-authors include Marianne Klemp, Per Nafstad, Lise Lund Håheim, Ingar Holme, Ivar Sønbø Kristiansen, Gunhild Hagen, Eva Pike, Vida Hamidi, Bente Oftedal and Ingvar Hjermann and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Torbjørn Wisløff

102 papers receiving 1.9k citations

Peers

Torbjørn Wisløff
Romain Neugebauer United States
Seok‐Jun Yoon South Korea
Jane Brock United States
Christie M. Bartels United States
Philippe Gamache Canada
Cynthia D. O’Malley United States
Richard T. Meenan United States
Ricard Tresserras Spain
Nawar Shara United States
Miguel Ángel Luque-Fernández United Kingdom
Romain Neugebauer United States
Torbjørn Wisløff
Citations per year, relative to Torbjørn Wisløff Torbjørn Wisløff (= 1×) peers Romain Neugebauer

Countries citing papers authored by Torbjørn Wisløff

Since Specialization
Citations

This map shows the geographic impact of Torbjørn Wisløff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torbjørn Wisløff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torbjørn Wisløff more than expected).

Fields of papers citing papers by Torbjørn Wisløff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torbjørn Wisløff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torbjørn Wisløff. The network helps show where Torbjørn Wisløff may publish in the future.

Co-authorship network of co-authors of Torbjørn Wisløff

This figure shows the co-authorship network connecting the top 25 collaborators of Torbjørn Wisløff. A scholar is included among the top collaborators of Torbjørn Wisløff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torbjørn Wisløff. Torbjørn Wisløff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Body, Richard, Paul Collinson, Fred S. Apple, et al.. (2025). Effectiveness of Point-of-Care High-Sensitivity Troponin Testing in the Emergency Department: A Randomized Controlled Trial. Annals of Emergency Medicine. 86(2). 124–135. 3 indexed citations
2.
Menichetti, Julia, Henrik Schirmer, Tone Breines Simonsen, et al.. (2024). What do patients with heart failure disclose about medication adherence at home to their hospital and primary care doctors? Exploratory interaction-based observational cohort study. BMJ Open. 14(8). e086440–e086440. 1 indexed citations
3.
Nilsen, Tormod S., Sebastian Imre Sarvari, Kristin V. Reinertsen, et al.. (2023). Effects of Aerobic Exercise on Cardiorespiratory Fitness, Cardiovascular Risk Factors, and Patient-Reported Outcomes in Long-Term Breast Cancer Survivors: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 12. e45244–e45244. 4 indexed citations
4.
Andreasen, Camilla, Cecilie Dahl, Lene Bergendal Solberg, et al.. (2023). Epidemiology of forearm fractures in women and men in Norway 2008–2019. Osteoporosis International. 35(4). 625–633. 2 indexed citations
5.
Aas, Eline, Karl Claxton, Mark Strong, et al.. (2023). General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations. Medical Decision Making. 43(5). 595–609. 3 indexed citations
6.
Pawaskar, Manjiri, et al.. (2021). Clinical and economic impact of universal varicella vaccination in Norway: A modeling study. PLoS ONE. 16(7). e0254080–e0254080. 14 indexed citations
7.
Strong, Mark, et al.. (2021). An Efficient Method for Computing Expected Value of Sample Information for Survival Data from an Ongoing Trial. Medical Decision Making. 42(5). 612–625. 4 indexed citations
8.
9.
Briggs, Andrew, Daniel A. Goldstein, Rachel Meacock, et al.. (2020). Estimating (quality‐adjusted) life‐year losses associated with deaths: With application to COVID‐19. Health Economics. 30(3). 699–707. 43 indexed citations
10.
Melbye, Hasse, Jon Helgeland, Øystein Karlstad, et al.. (2020). <p>Is the Disease Burden from COPD in Norway Falling off? A Study of Time Trends in Three Different Data Sources</p>. International Journal of COPD. Volume 15. 323–334. 7 indexed citations
11.
Evensen, Stig, Torbjørn Wisløff, June Ullevoldsæter Lystad, et al.. (2019). Exploring the potential cost-effectiveness of a vocational rehabilitation program for individuals with schizophrenia in a high-income welfare society. BMC Psychiatry. 19(1). 140–140. 12 indexed citations
12.
Wisløff, Torbjørn, et al.. (2019). <p>Cost comparison analysis of laparoscopic versus open aortobifemoral bypass surgery: a randomized controlled trial</p>. Duo Research Archive (University of Oslo). Volume 11. 11–18. 2 indexed citations
13.
Wisløff, Torbjørn, Liv Mundal, Kjetil Retterstøl, Jannicke Igland, & Ivar Sønbø Kristiansen. (2019). Economic evaluation of lipid lowering with PCSK9 inhibitors in patients with familial hypercholesterolemia: Methodological aspects. Atherosclerosis. 287. 140–146. 11 indexed citations
14.
Flem, Elmira, et al.. (2019). Healthcare costs associated with varicella and herpes zoster in Norway. Vaccine. 37(29). 3779–3784. 13 indexed citations
15.
Wisløff, Torbjørn, Richard White, Olav Dalgård, et al.. (2018). Feasibility of reaching world health organization targets for hepatitis C and the cost‐effectiveness of alternative strategies. Journal of Viral Hepatitis. 25(9). 1066–1077. 6 indexed citations
16.
Wisløff, Torbjørn, Richard White, Olav Dalgård, et al.. (2018). Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway. PharmacoEconomics. 36(5). 591–601. 10 indexed citations
17.
Wahl, Astrid Klopstad, et al.. (2016). Long-term, self-reported health outcomes in kidney donors. BMC Nephrology. 17(1). 8–8. 24 indexed citations
18.
Wisløff, Torbjørn, Tove Ringerike, Gunhild Hagen, Åsmund Reikvam, & Marianne Klemp. (2013). Efficacy and cost-effectiveness of new oral anticoagulants compared to warfarin for the prevention of stroke in patients with atrial fibrillation. 4 indexed citations
19.
Wisløff, Torbjørn, Randi Selmer, Sigrun Halvorsen, & Ivar Sønbø Kristiansen. (2008). Norwegian Cardiovascular Disease Model (NorCaD) – a simulation model for estimating health benefi ts and cost consequences of cardiovascular interventions. Duo Research Archive (University of Oslo). 14 indexed citations
20.
Halvorsen, Sigrun, et al.. (2004). Kostnader og nytte ved å erstatte trombolyse med PCI ved akutt hjerteinfarkt. Duo Research Archive (University of Oslo).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Romain Neugebauer Breakdown of academic impact, for papers by Seok‐Jun Yoon Breakdown of academic impact, for papers by Jane Brock Breakdown of academic impact, for papers by Christie M. Bartels Breakdown of academic impact, for papers by Philippe Gamache Breakdown of academic impact, for papers by Cynthia D. O’Malley Breakdown of academic impact, for papers by Richard T. Meenan Breakdown of academic impact, for papers by Ricard Tresserras Breakdown of academic impact, for papers by Nawar Shara Breakdown of academic impact, for papers by Miguel Ángel Luque-Fernández
Rankless by CCL
2026